NYSE:BCSFBain Capital Specialty Finance Stock Price, Forecast & News

Bain Capital Specialty Finance's stock was trading at $16.84 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, BCSF stock has decreased by 38.9% and is now trading at $10.29. View which stocks have been most impacted by Coronavirus.

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Bain Capital Specialty Finance in the last year. There are currently 1 sell rating, 3 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Bain Capital Specialty Finance.

Bain Capital Specialty Finance is scheduled to release its next quarterly earnings announcement on Wednesday, August 5th 2020. View our earnings forecast for Bain Capital Specialty Finance.

Bain Capital Specialty Finance Inc (NYSE:BCSF) posted its earnings results on Monday, May, 4th. The company reported $0.44 earnings per share for the quarter, topping the Thomson Reuters' consensus estimate of $0.41 by $0.03. The firm earned $51.50 million during the quarter, compared to analysts' expectations of $54.41 million. Bain Capital Specialty Finance had a negative net margin of 21.80% and a positive return on equity of 8.72%. View Bain Capital Specialty Finance's earnings history.

Bain Capital Specialty Finance declared a quarterly dividend on Monday, May 4th. Shareholders of record on Tuesday, June 30th will be given a dividend of $0.41 per share on Thursday, July 30th. This represents a $1.64 dividend on an annualized basis and a dividend yield of 15.94%. The ex-dividend date of this dividend is Monday, June 29th. View Bain Capital Specialty Finance's dividend history.

5 equities research analysts have issued twelve-month price objectives for Bain Capital Specialty Finance's shares. Their forecasts range from $7.50 to $19.50. On average, they anticipate Bain Capital Specialty Finance's share price to reach $12.20 in the next year. This suggests a possible upside of 18.6% from the stock's current price. View analysts' price targets for Bain Capital Specialty Finance.

Media headlines about BCSF stock have been trending negative recently, InfoTrie reports. The research group identifies positive and negative media coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Bain Capital Specialty Finance earned a coverage optimism score of -2.1 on InfoTrie's scale. They also gave news headlines about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the stock's share price in the near future. View the latest news aboutBain Capital Specialty Finance.

Bain Capital Specialty Finance saw a increase in short interest in the month of April. As of April 30th, there was short interest totaling 822,500 shares, an increase of 20.4% from the April 15th total of 683,400 shares. Based on an average daily volume of 384,900 shares, the short-interest ratio is currently 2.1 days. Approximately 1.6% of the shares of the company are short sold. View Bain Capital Specialty Finance's Current Options Chain.

Some companies that are related to Bain Capital Specialty Finance include Vivint Smart Home (VVNT), Verra Mobility (VRRM), Immunovant (IMVT), GS ACQUISITION /SH CL A (GSAH), AdaptHealth (AHCO), HAYMAKER ACQUIS/SH CL A (HYAC), Grid Dynamics (GDYN), Alberton Acquisition (CFFA), Gores Holdings III (GRSH), Global Cord Blood (CO), Thunder Bridge Acquisition II (SSPK), Crescent Capital BDC (CCAP), Leisure Acquisition (NEBU), FORUM MERGER II/SH CL A (FMCI) and Andina Acquisition Corp. III (AMCI). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Bain Capital Specialty Finance investors own include Verizon Communications (VZ), Honeywell International (HON), CVS Health (CVS), Home Depot (HD), Altria Group (MO), Pfizer (PFE), AT&T (T), Alibaba Group (BABA), Cisco Systems (CSCO) and Walt Disney (DIS).

(BCSF) raised $156 million in an IPO on Thursday, November 15th 2018. The company issued 7,500,000 shares at a price of $20.25-$21.25 per share. BofA Merrill Lynch, Goldman Sachs, Morgan Stanley, Citigroup, Credit Suisse, Keefe, Bruyette & Woods (A Stifel Company) and Wells Fargo Securities acted as the underwriters for the IPO and Janney Montgomery Scott, JMP Securities and Academy Securities were co-managers.

Bain Capital Specialty Finance trades on the New York Stock Exchange (NYSE) under the ticker symbol "BCSF."

Bain Capital Specialty Finance's stock is owned by a number of institutional and retail investors. Top institutional investors include Bain Capital Credit LP (16.84%), Employees Retirement System of Texas (7.96%), Dimension Capital Management LLC (7.26%), UBS Group AG (2.87%), HighTower Advisors LLC (1.06%) and Van ECK Associates Corp (0.83%). Company insiders that own Bain Capital Specialty Finance stock include Amy Butte, Clare Stack Richer, Jeffrey B Hawkins, Michael A Ewald, Michael John Boyle and Thomas A Hough. View institutional ownership trends for Bain Capital Specialty Finance.

BCSF stock was sold by a variety of institutional investors in the last quarter, including UBS Group AG, Dimension Capital Management LLC, Two Sigma Investments LP, Morgan Stanley, Glovista Investments LLC, Muzinich & Co. Inc., One Charles Private Wealth Services LLC, and Spark Investment Management LLC. View insider buying and selling activity for Bain Capital Specialty Finance.

BCSF stock was bought by a variety of institutional investors in the last quarter, including Bain Capital Credit LP, Employees Retirement System of Texas, Sumitomo Mitsui Trust Holdings Inc., Two Sigma Advisers LP, IHT Wealth Management LLC, Radcliffe Capital Management L.P., First Trust Advisors LP, and Van ECK Associates Corp. Company insiders that have bought Bain Capital Specialty Finance stock in the last two years include Amy Butte, Clare Stack Richer, Jeffrey B Hawkins, Michael A Ewald, Michael John Boyle, and Thomas A Hough. View insider buying and selling activity for Bain Capital Specialty Finance.

Shares of BCSF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of BCSF stock can currently be purchased for approximately $10.29.

Bain Capital Specialty Finance has a market capitalization of $531.48 million and generates $197.95 million in revenue each year. The company earns $98.08 million in net income (profit) each year or $1.64 on an earnings per share basis.

The official website for Bain Capital Specialty Finance is www.baincapital.com.

Bain Capital Specialty Finance's mailing address is 200 CLARENDON STREET 37TH FLOOR, BOSTON MA, 02116. The company can be reached via phone at 617-516-2000 or via email at [email protected]